Evidence map›Paper›PMID 38188000›Full record

ArticleExtracellular vesicle2023

Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways.

Michail Spanos, Priyanka Gokulnath, Emeli Chatterjee, Guoping Li, Dimitrios Varrias, Saumya Das

Open access · diamondAbstract read
In one paragraph

Article in Extracellular vesicle, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Circulating long noncoding RNA: New frontiers in biomarker research for mood disorders.Genomic psychiatry : advancing science from genes to society · 2025
    Article
  15. Extracellular vesicle therapeutics for cardiac repair.Journal of molecular and cellular cardiology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michail SpanosCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Priyanka GokulnathCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Emeli ChatterjeeCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Guoping LiCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Dimitrios VarriasAlbert Einstein College of Medicine/Jacobi Medical Center, The Bronx, NY, USA.
Saumya DasCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Harvard University · USJacobi Medical Center · US

Funding

Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failureR35HL150807 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Saumya Das · 2020 to 2026
$6.7M
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM diseaseR01DK133847 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, KULKARNI, ROHIT N. · 2022 to 2025
$3.0M
Molecular dissection and imaging of extracellular vesicles to define their origin and targetsUG3TR002878 · NCATS · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, TALISMAN, TIJANA · 2019 to 2020
$939k
NCATS NIH HHS UG3 TR002878NHLBI NIH HHS R35 HL150807NIDDK NIH HHS R01 DK133847
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are membrane-bound nanoparticles with different types of cargo released by cells and postulated to mediate functions such as intercellular communications. Recent studies have shown that long non-coding RNAs (lncRNAs) or their fragments are present as cargo within EVs. LncRNAs are a heterogeneous group of RNA species with a length exceeding 200 nucleotides with diverse functions in cells based on their localization. While lncRNAs are known for their important functions in cellular regulation, their presence and role in EVs have only recently been explored. While certain studies have observed EV-lncRNAs to be tissue-and disease-specific, it remains to be determined whether or not this is a global observation. Nonetheless, these molecules have demonstrated promising potential to serve as new diagnostic and prognostic biomarkers. In this review, we critically evaluate the role of EV-derived lncRNAs in several prevalent diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases, with a specific focus on their role as biomarkers.

Indexed as

CancerCardiovascular diseaseExtracellular vesiclesLong-noncoding RNANeurological disease

Identifiers

PMID38188000
PMCPMC10768935
OpenAlexW4377157508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.